VACCINES ADJUVANT DEVELOPMENT PROGRAM IN INFECTIOUS AND IMMUNE MEDIATED DISEASES Solicitation ID/Procurement Identifier: 75N93022R00009 Ultimate Completion Date: Fri Sep 29 17:00:00 GMT 2028
As one component of the VRC’s research, the VRC, NIAID, NIH has been investigating the use of novel adjuvants in our vaccine development program for HIV, influenza and other viral vaccines, and has found the “Adjuplex brand” of adjuvant from Advanced BioAdjuvants LLC (ABA) to be superior to other adjuvants.
Outline Agreement Number:- 4600047162 , Vendor:- Merck & Co. ,Buyer Name:- Heather Bailey
Vaccines PA #: MMS2000294 Vendors: Pfizer Inc. Catalog: Health and Hospitals Award Date: Wednesday, July 8 2020 Expires on: Sunday, June 30 2024
VACCINES PA #: MMS2000315 Vendors: Merck & Co. Catalog: Health and Hospitals Award Date: Wednesday, July 1 2020 Expires on: Sunday, June 30 2024
Vaccines PA #: MMS2000294 Vendors: Pfizer Inc. Catalog: Health and Hospitals Award Date: Wednesday, July 8 2020 Expires on: Sunday, June 30 2024
VACCINES PA #: MMS2000315 Vendors: Merck & Co. Catalog: Health and Hospitals Award Date: Wednesday, July 1 2020 Expires on: Sunday, June 30 2024
